Teddi Mellencamp Defends Cosmetic Surgery During Stage 4 Cancer Treatment: What Patients Should Know
Teddi Mellencamp has defended her decision to undergo cosmetic surgery while receiving treatment for stage 4 cancer, revealing that her cancer doctors approved the procedure before she agreed to go ahead.
The Real Housewives of Beverly Hills alum, 45, recently underwent an upper blepharoplasty, a procedure that removes excess skin from the upper eyelids. After footage shared by her plastic surgeon prompted questions from followers, Mellencamp addressed the decision on Instagram Stories, making clear that it was not undertaken without medical approval.
'Of course, it was fine with my cancer doctors; that's why I agreed to do it,' she said.
The procedure has drawn attention because Mellencamp continues to receive immunotherapy following a melanoma diagnosis that progressed to her brain and lungs. Her experience also raises an important question for patients: when is elective surgery appropriate during cancer treatment?
Why Did Teddi Mellencamp Undergo Eyelid Surgery?
Mellencamp's surgeon, Beverly Hills-based Dr Sarmela Sunder, shared footage of the procedure, explaining that the reality star had been bothered by excess skin on her upper eyelids for several years.
According to Sunder, the loose skin had become heavy enough to affect Mellencamp's daily comfort. She also described involuntarily raising her eyebrows to lift her eyelids, contributing to forehead lines and fatigue around her face.
Sunder said Mellencamp had wanted the procedure for some time but waited until her oncologists medically cleared her. The operation was performed under local anaesthesia, meaning she remained awake.
Mellencamp also revealed that she had immunotherapy scheduled shortly after the procedure and expected to have her stitches removed within days.
Understanding Her Cancer Treatment
Mellencamp was diagnosed with stage 2 melanoma in 2022. By 2025, the cancer had spread to her brain and lungs, requiring further treatment, including surgery to remove brain tumours.
In October 2025, Mellencamp said doctors had found no detectable cancer. However, she continued immunotherapy and clarified that this did not mean she had been formally declared in remission.
Her latest procedure was cosmetic rather than cancer-directed. The distinction matters because patients receiving cancer treatment may have different medical considerations depending on their diagnosis, treatment plan, and overall health.
What Should Patients Know About Cosmetic Surgery During Cancer Treatment?
Mellencamp's experience should not be interpreted as evidence that cosmetic surgery is safe for everyone receiving cancer treatment. Her procedure went ahead after her own cancer doctors assessed and approved it.
The suitability of elective surgery depends on individual circumstances, including the type of procedure, the patient's general health, current medications, and the treatment being received. Surgery can carry risks such as bleeding, infection and delayed healing, while anaesthesia and recovery requirements also need consideration.
The American Cancer Society advises patients to discuss surgical risks with their healthcare team and understand the potential benefits, complications and recovery requirements before proceeding.
Anyone receiving cancer treatment who is considering an elective procedure should consult their oncologist and surgeon before making a decision. They can assess whether the timing is appropriate, whether any adjustments are needed, and how the procedure might affect ongoing treatment.
Mellencamp's case illustrates that a cancer diagnosis does not automatically settle every decision about a patient's appearance or quality of life. However, medical clearance is central to determining whether an elective procedure is appropriate for the individual.